ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,943,796 | -43.4% | 1,628,781 | -35.0% | 0.04% | -41.2% |
| Q2 2023 | $59,981,457 | +17.4% | 2,504,445 | -7.7% | 0.07% | +15.3% |
| Q1 2023 | $51,086,607 | +11.3% | 2,714,485 | -5.8% | 0.06% | +7.3% |
| Q4 2022 | $45,887,556 | -3.9% | 2,882,361 | -1.3% | 0.06% | -11.3% |
| Q3 2022 | $47,769,000 | +56.1% | 2,919,860 | +34.5% | 0.06% | +63.2% |
| Q2 2022 | $30,593,000 | -45.8% | 2,171,242 | -6.9% | 0.04% | -34.5% |
| Q1 2022 | $56,485,000 | -27.8% | 2,332,154 | -30.4% | 0.06% | -23.7% |
| Q4 2021 | $78,256,000 | +81.0% | 3,352,883 | +28.8% | 0.08% | +65.2% |
| Q3 2021 | $43,227,000 | -39.4% | 2,602,463 | -11.0% | 0.05% | -40.3% |
| Q2 2021 | $71,332,000 | +75.3% | 2,924,637 | +85.4% | 0.08% | +57.1% |
| Q1 2021 | $40,690,000 | -53.1% | 1,577,121 | -2.8% | 0.05% | -57.4% |
| Q4 2020 | $86,743,000 | +22.5% | 1,622,576 | -5.5% | 0.12% | +1.8% |
| Q3 2020 | $70,832,000 | +2.9% | 1,717,131 | +20.9% | 0.11% | -5.0% |
| Q2 2020 | $68,839,000 | +13.4% | 1,420,248 | -1.1% | 0.12% | -13.1% |
| Q1 2020 | $60,686,000 | -0.7% | 1,436,349 | +0.6% | 0.14% | +31.7% |
| Q4 2019 | $61,110,000 | -32.9% | 1,428,460 | -43.5% | 0.10% | -39.2% |
| Q3 2019 | $91,068,000 | -19.2% | 2,530,363 | -40.0% | 0.17% | -19.7% |
| Q2 2019 | $112,776,000 | -12.8% | 4,219,069 | -12.4% | 0.21% | -17.1% |
| Q1 2019 | $129,304,000 | +93.2% | 4,815,776 | +16.4% | 0.26% | +61.6% |
| Q4 2018 | $66,923,000 | -45.1% | 4,138,725 | -29.5% | 0.16% | -30.0% |
| Q3 2018 | $121,876,000 | +206.6% | 5,870,693 | +125.5% | 0.23% | +176.8% |
| Q2 2018 | $39,755,000 | +0.4% | 2,603,446 | +47.7% | 0.08% | -9.9% |
| Q1 2018 | $39,615,000 | -13.6% | 1,763,021 | +15.8% | 0.09% | -16.5% |
| Q4 2017 | $45,861,000 | +0.6% | 1,523,112 | +25.8% | 0.11% | -6.8% |
| Q3 2017 | $45,597,000 | +16.6% | 1,210,441 | -13.7% | 0.12% | +12.5% |
| Q2 2017 | $39,103,000 | +30.4% | 1,402,029 | +60.8% | 0.10% | +25.3% |
| Q1 2017 | $29,977,000 | -3.1% | 871,926 | -18.7% | 0.08% | -9.8% |
| Q4 2016 | $30,930,000 | +18.2% | 1,072,458 | +30.4% | 0.09% | +17.9% |
| Q3 2016 | $26,165,000 | -5.9% | 822,536 | -3.9% | 0.08% | -11.4% |
| Q2 2016 | $27,796,000 | – | 856,324 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |